Chongqing Genrix Biopharmaceutical Co., Ltd. (SHA:688443)
23.75
-0.45 (-1.86%)
At close: Nov 17, 2026
Chongqing Genrix Biopharmaceutical Employees
Chongqing Genrix Biopharmaceutical had 1,133 employees as of June 30, 2026. The number of employees increased by 149 or 15.14% since the number was reported on December 31, 2025. That makes Chongqing Genrix Biopharmaceutical the 13,997th largest employer in the world and 3,222nd in China.
Employees
1,133
Change
149
Growth
15.14%
Revenue / Employee
706.95K CNY
Profits / Employee
-184.85K CNY
Market Cap
8.71B
Employees Chart
| Date | Employees | Change | Growth |
|---|---|---|---|
| Jun 30, 2026 | 1,133 | 149 | 15.14% |
| Dec 31, 2025 | 984 | 241 | 32.44% |
| Dec 31, 2024 | 743 | 196 | 35.83% |
| Dec 31, 2023 | 547 | 155 | 39.54% |
| Dec 31, 2022 | 392 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Chengzhi | 4,462 |
| Tibet Cheezheng Tibetan Medicine | 3,203 |
| Shanghai Medicilon | 2,780 |
| Pacific Shuanglin Bio-pharmacy | 2,755 |
| Jiangsu Sinopep-Allsino Biopharmaceutical | 2,360 |
| Liaoning Chengda Biotechnology | 1,585 |
| Mabwell (Shanghai) Bioscience | 1,356 |
| Hualan Biological Vaccine | 708 |